Tawazun Health’s globally recognised expertise is helping find, manage, and reverse the fatty liver pandemic with FibroScan®.
1 in 3
of the world’s population
lives with Fatty Liver Disease (FLD).*
Untreated FLD leads to inflammation, cirrhosis, type 2 diabetes, hypertension, cardiovascular illness and ultimately liver cancer. FibroScan® screening is the simple and effective method to diagnose and fight FLD before it takes hold.
FLD is likely to become the leading cause of end-stage liver disease in the coming decades. But we can do something about it today.
*(Journal of Hepatology, 2023)
Hear from our founder
Louise Campbell is a globally recognised leader in liver health and a Fellow of The Royal College of Physicians. Louise’s experience includes leading teams that have used FibroScan® across 4 continents, assisting governments in public health initiatives and discussing Fatty Liver Disease on major news platforms.
Interested in a consult?
Click here to book a consultation and FibroScan® with Louise Campbell at our Tawazun Health HQ, in Harley Street London.
FibroScan® is a non-invasive, quick and painless test recognised as the new standard for Fatty Liver Disease (FLD) diagnosis
With over 4,800 medical publications worldwide, and recommendations in 180 clinical guidelines, major institutions worldwide including the Global Liver Institute, British Liver Trust and Australian Liver Foundation support FibroScan®.
FibroScan® uses sound waves to measure liver fattiness and stiffness
FibroScan® is a painless, non-invasive method for identifying the early signs of FLD. Unlike blood tests and biopsies, there is no discomfort, no sample handling, and no need to wait for results.
Actionable results, fast
Each FibroScan® takes just 15 minutes and results are ready immediately. Presenting liver health scores in a simple ‘traffic light’ system has proven exceedingly effective in sparking positive lifestyle changes.
Learn more about the process of having a FibroScan® with Echosens’ training tutorial.
Our Partners:
Corporate
FibroScan® helps you make a healthy workforce your competitive advantage, reducing the costs of low productivity and absenteeism caused by FLD.
Health Screening
Tawazun Health is dedicated to improving standards for FLD screening and management through research, education and innovation.
Public Health
Working with health authorities globally to improve patient outcomes by introducing FibroScan® into primary care at the earliest opportunities to prevent the onset of avoidable diseases.
Individual
We are committed to making FibroScan® accessible and affordable, with instant results and simple actionable lifestyle recommendations for you.
Latest from Tawazun
Tawazun Health supports the PBC Foundation Patient Conference in Edinburgh with FibroScan® Technology
Enhancing PBC Patient Care with FibroScan® Technology Louise and the Tawazun Health team were honoured to support the PBC Foundation at their recent Patient Conference held in Edinburgh, Scotland, on the 7th and 8th of September. The team were able to provide and to...
Insights from the 2024 EASL Congress: A Focus on Youth and Gender Diversity
The 2024 European Association for the Study of the Liver (EASL) Congress, held on the 5th and 6th of June in Milan, Italy, brought together an impressive gathering of professionals in the hepatology field. 7,809 delegates, 401 faculty members and 5,500 participants...
The Path to Liver Health – Understanding Liver Stiffness
Your liver plays a vital role in your overall health and wellbeing, and understanding liver stiffness is essential in helping you maintain a healthy liver and lifestyle. In this latest article, we will take a closer look into what liver stiffness is, how it is...